Johnson & Johnson (JNJ)
155.50
+2.39
(+1.56%)
USD |
NYSE |
Nov 21, 16:00
155.02
-0.48
(-0.31%)
Pre-Market: 04:26
Johnson & Johnson Shareholders Equity (Quarterly): 70.16B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 70.16B |
June 30, 2024 | 71.54B |
March 31, 2024 | 70.02B |
December 31, 2023 | 68.77B |
September 30, 2023 | 71.23B |
June 30, 2023 | 75.15B |
March 31, 2023 | 70.87B |
December 31, 2022 | 76.80B |
September 30, 2022 | 74.60B |
June 30, 2022 | 76.36B |
March 31, 2022 | 74.71B |
December 31, 2021 | 74.02B |
September 30, 2021 | 70.27B |
June 30, 2021 | 69.58B |
March 31, 2021 | 65.83B |
December 31, 2020 | 63.28B |
September 30, 2020 | 64.47B |
June 30, 2020 | 62.98B |
March 31, 2020 | 61.29B |
December 31, 2019 | 59.47B |
September 30, 2019 | 58.21B |
June 30, 2019 | 60.78B |
March 31, 2019 | 58.96B |
December 31, 2018 | 59.75B |
September 30, 2018 | 64.63B |
Date | Value |
---|---|
June 30, 2018 | 62.89B |
March 31, 2018 | 63.26B |
December 31, 2017 | 60.16B |
September 30, 2017 | 73.98B |
June 30, 2017 | 71.92B |
March 31, 2017 | 70.34B |
December 31, 2016 | 70.42B |
September 30, 2016 | 72.77B |
June 30, 2016 | 72.47B |
March 31, 2016 | 72.65B |
December 31, 2015 | 71.15B |
September 30, 2015 | 71.55B |
June 30, 2015 | 71.13B |
March 31, 2015 | 67.88B |
December 31, 2014 | 69.75B |
September 30, 2014 | 76.59B |
June 30, 2014 | 78.05B |
March 31, 2014 | 76.58B |
December 31, 2013 | 74.05B |
September 30, 2013 | 69.80B |
June 30, 2013 | 69.66B |
March 31, 2013 | 66.86B |
December 31, 2012 | 64.83B |
September 30, 2012 | 63.76B |
June 30, 2012 | 60.43B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
59.47B
Minimum
Dec 2019
76.80B
Maximum
Dec 2022
69.57B
Average
70.22B
Median
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 7.527B |
Eli Lilly and Co | 14.24B |
Merck & Co Inc | 44.50B |
Pfizer Inc | 92.29B |
AbbVie Inc | 6.032B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 178.29B |
Total Liabilities (Quarterly) | 108.13B |
Debt to Equity Ratio | 0.5096 |
Current Ratio | 1.029 |
Net Debt Paydown Yield | 0.50% |